Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Sudden death due to troponin T mutations.

Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, Watkins H.

J Am Coll Cardiol. 1997 Mar 1;29(3):549-55.

2.

[Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].

Sadoul N, de Chillou C, Aliot E, McKenna WJ.

Arch Mal Coeur Vaiss. 1999 Apr;92 Spec No 1:65-73. Review. French.

PMID:
10326160
3.

Malignant mutations in hypertrophic cardiomyopathy: fact or fancy?

Brito D, Madeira H.

Rev Port Cardiol. 2005 Sep;24(9):1137-46. Review. English, Portuguese.

4.

Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.

Marian AJ, Roberts R.

Ann Med. 1998 Aug;30 Suppl 1:24-32. Review.

PMID:
9800880
5.

Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death.

Marian AJ, Roberts R.

J Cardiovasc Electrophysiol. 1998 Jan;9(1):88-99. Review.

PMID:
9475582
6.

Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy.

Watkins H, Seidman JG, Seidman CE.

Hum Mol Genet. 1995;4 Spec No:1721-7. Review.

PMID:
8541871
7.

Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.

Keren A, Syrris P, McKenna WJ.

Nat Clin Pract Cardiovasc Med. 2008 Mar;5(3):158-68. doi: 10.1038/ncpcardio1110. Epub 2008 Jan 29. Review. Erratum in: Nat Clin Pract Cardiovasc Med. 2008 Nov;5(11):747.

PMID:
18227814
8.

[Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].

Ramírez CD, Padrón R.

Invest Clin. 2004 Mar;45(1):69-99. Review. Spanish.

PMID:
15058760
9.

[Genetic changes and clinical management in familial hypertrophic cardiomyopathy].

Domal-Kwiatkowska D, Smolik S, Mazurek U, Moric E, Polońska J, Nowalany-Kozielska E, Glanowska G, Wodniecki J, Szarek J, Wilczewski P, Kozakiewicz K, Tendera M, Wilczok T.

Wiad Lek. 2000;53(1-2):4-21. Review. Polish.

PMID:
10806915
11.

[Genotype-phenotype correlations in familial hypertrophic cardiomyopathy].

Anan R, Niimura H, Tei C.

Nihon Rinsho. 2000 Jan;58(1):134-40. Review. Japanese.

PMID:
10885301
12.

Familial hypertrophic cardiomyopathy: from mutations to functional defects.

Bonne G, Carrier L, Richard P, Hainque B, Schwartz K.

Circ Res. 1998 Sep 21;83(6):580-93. Review.

13.

The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.

Sorajja P, Elliott PM, McKenna WJ.

Europace. 2000 Jan;2(1):4-14. Review. No abstract available.

PMID:
11225594
14.

A systematic review and meta-analysis of genotype-phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations.

Lopes LR, Rahman MS, Elliott PM.

Heart. 2013 Dec;99(24):1800-11. doi: 10.1136/heartjnl-2013-303939. Epub 2013 May 14. Review.

PMID:
23674365
15.

Molecular and clinical aspects of inherited cardiomyopathies.

Durand JB, Abchee AB, Roberts R.

Ann Med. 1995 Jun;27(3):311-7. Review.

PMID:
7546620
16.

The molecular genetics of cardiovascular disease.

Anderson PA.

Curr Opin Cardiol. 1995 Jan;10(1):33-43. Review.

PMID:
7787263
17.

Risk stratification in hypertrophic cardiomyopathy.

Vassalli G, Seiler C, Hess OM.

Curr Opin Cardiol. 1994 May;9(3):330-6. Review.

PMID:
8049590
18.

[Myocardiopathies (II). Genetic changes in the etiopathogenesis of hypertrophic myocardiopathy. The therapeutic prospects].

Reyes Engel A, Diéguez Lucena JL, Galván ET, Espinosa Caliani S.

Rev Esp Cardiol. 1995 Oct;48(10):677-85. Review. Spanish.

PMID:
7481037
19.

[Cardiomyopathies from the aspect of molecular cardiology].

Kölbel F.

Cas Lek Cesk. 1994 Jun 27;133(13):401-3. Review. Czech.

PMID:
8062332
20.

Hypertrophic cardiomyopathy: an update.

McKenna WJ.

Cardiologia. 1993 Dec;38(12 Suppl 1):277-81. Review.

PMID:
8020027

Supplemental Content

Support Center